King Pharmaceuticals has a well-recognized and highly prescribed portfolio of core-marketed products. Our leading brands include Avinza® CII, a once-daily morphine treatment for chronic pain; Skelaxin®, for relief from discomfort associated with acute musculoskeletal conditions; Thrombin-JMI®, which aids in controlling bleeding during surgery; Altace®, an ACE inhibitor; Sonata® CIV, one of three approved non-benzodiazepine treatments for insomnia; Levoxyl®, for the treatment of thyroid disorders; and Meridian Auto injector Products/EpiPen®.
©2000-2008 King Pharmaceuticals,® Inc. All rights reserved.
